Source: International Congress 2014 – Tuberculosis epidemiology: novel features
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. L. Gill, L. P. Ormerod, T. Collyns, J. P. Watson (Leeds, Blackburn, United Kingdom). Positive predictive value of an interferon-gamma release assay for progression from latent to active tuberculosis in new-entrant screening. Eur Respir J 2014; 44: Suppl. 58, 1697

Member's Comments

No comment yet.

Related content which might interest you: Outcomes of early interferon-gamma release assay (IGRA) testing in recent contacts of smear positive pulmonary tuberculosis (TB) Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013 Risk of tuberculosis in dialysis population: Revising the predictive value of interferon-gamma releasing assay Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016 Latent TB infection in health care TB workers Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 New-immigrant screening for latent tuberculosis infection: Reasons for non-treatment Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis Year: 2013 Age as a factor affecting the diagnostic accuracy of TB lymphadenitis Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015 Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Predictive factors of a delayed culture conversion under tuberculosis treatment Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 The value of immunological methods in the diagnosis of tuberculosis in patients with HIV Source: International Congress 2015 – Screening strategies in TB Year: 2015 Prevention of latent TB reactivation in rheumatology patients prior to anti-TNF therapy: Evaluation of a risk stratification strategy in a low prevalence area Source: International Congress 2015 – Screening strategies in TB Year: 2015 Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Safety of two step tuberculin skin test (TST) in the screening of healthcare workers for latent TB infection (LTBI) Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 The effect of smoking on QuantiFERON results in diagnosis of latent tuberculosis infection Source: International Congress 2016 – Latent tuberculosis infection Year: 2016 Liver injury in treatment of latent tuberculosis infection - is the age cut-off for treatment justified? Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014 Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016 Low real-world utility of IGRA when screening for LTBI in a low incidence setting Source: International Congress 2015 – Screening strategies in TB Year: 2015 CD27 expression as a new tool to distinguish active tuberculosis from latent infection Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 Tuberculin skin testing to the IGRA positive contacts of infectious tuberculosis cases for the treatment of latent tuberculosis infection Source: International Congress 2015 – Latent TB infection and screening Year: 2015 Correlation between tuberculin-skin-test and interferon-gamma-release-assays with risks factors for tuberculosis infection Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013